1.Construction of eukaryotic expression vectors of FGFR3 gene and their expressions in human leukemia K562 cell line
Huijing XU ; Tonghua DU ; Yan SUN ; Xiaokun LI ; Yechen XIAO
Journal of Jilin University(Medicine Edition) 2014;(3):465-470
Objective To construct the eukaryotic expression vectors of fibroblast growth factor receptor 3(FGFR3) MSCV/puro-fgfr3-WT and MSCV/puro-fgfr3-DN, and to detect their expressions in human chronic myeloid leukemia(CML)K562 cell line.Methods The full-length FGFR3 (fgfr3-WT)and dominant negative FGFR3 (fgfr3-DN)were amplified by polymerase chain reaction (PCR). The two genes were respectively digested with EcoRⅠand BamHⅠ,and then ligated into MSCV/puro to construct the recombinant plasmids MSCV/puro-fgfr3-WT and MSCV/puro-fgfr3-DN which were tranduced into K562 cells by LipofectaminTM 2000 after PCR,double digestion and DNA sequencing.The expressions of FGFR3 protein in K562 cells were detected by Western blotting and flow cytometry. Results The recombinant plasmids MSCV/puro-fgfr3-WT and MSCV/puro-fgfr3-DN were amplified by PCR method, and the results showed fgfr3-WT of 2 400 bp and fgfr3-DN of 1 200 bp had been successfully cloned into MSCV-puro vector. The 2 400 bp fragment was oblained after double digestion of recombinant plasmid.The sequencing results showed that the size of fgfr3-WT was 2 400 bp which was the same as the sequence from GeneBank.Fgfr3-DN of 1 200 bp was also in conformity with the expected sequence.Compared with control (K562 MSCV)group,the expression level of FGFR3-WT in MSCV/puro-fgfr3-WT transfection (K562-WT)group was increased to above 10 times.There was high expression of FGFR3-DN in MSCV/puro-FGFR3-DN transfection (K562-DN)group,but there was no expressions in control(K562 MSCV)group and K562-WT group.The flow cytometry results showed that the high expressions of FGFR3-WT were in 57.5% cells in K562-DN group and the high expressions of FGFR3-DN were in 41.5% cells in K562-DN group. Conclusion The K562 cell lines highly expressing FGFR3-WT and FGFR3-DN are constructed successfully.
2.The application of tissue expander in immediate breast reconstruction
Zhenyu WANG ; Xiaoman JIANG ; Tonghua DU ; Yan ZHANG
Chinese Journal of Endocrine Surgery 2019;13(2):93-96
Objective To investigate the surgical procedure,complication and cosmetic effects of tissue expander in immediate breast reconstruction after nipple sparing mastectomy(NSM).Methods From Jul.2014 to Apr.2018,the clinical data of 23 breast cancer patients (two patients were bilateral) undergoing NSM and expander immediate breast reconstruction were analyzed retrospectively.Results All of the 25 procedures were NSM plus expander based immediate breast reconstruction.The overall complication rate was 12%,including:one seroma,one mild nipple necrosis and one nipple malposition.The median follow up period was 12 months,no grade Ⅲ or Ⅳ contractures were found.Appearance satisfaction was applied to the Harvard scoring system,doctor score:fair(2 cases;8%),good(2 cases;8%),excellent(21 cases;84%);patient score:good(4 cases;16%),excellent(21 cases;84%).No local recurrence was observed.Conclusion NSM with lateral incision and immediate reconstruction was found to be technically feasible and associated with few complications and satisfactory esthetic outcomes.